145 related articles for article (PubMed ID: 3155428)
1. Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease.
Feldman RL; Prida XE; Lambert CR; Hill JA
Cardiovasc Drugs Ther; 1988 Sep; 2(3):355-61. PubMed ID: 3155428
[TBL] [Abstract][Full Text] [Related]
2. Systemic and coronary hemodynamic effects of combined oral alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress tests.
Feldman RL; Prida XE; Hill JA
Clin Cardiol; 1988 Jun; 11(6):383-8. PubMed ID: 3396239
[TBL] [Abstract][Full Text] [Related]
3. Systemic and coronary hemodynamic effects of combined alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress test responses.
Prida XE; Hill JA; Feldman RL
Am J Cardiol; 1987 May; 59(12):1084-8. PubMed ID: 2883869
[TBL] [Abstract][Full Text] [Related]
4. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
Koch G
Acta Med Scand; 1986; 219(1):17-22. PubMed ID: 2869648
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects at rest and during exercise of combined alpha/beta-receptor blockade and of beta-receptor blockade alone in patients with ischemic heart disease.
Koch G; Fransson L
J Cardiovasc Pharmacol; 1987 Oct; 10(4):474-8. PubMed ID: 2444802
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic tolerability and anti-ischemic efficacy of high dose intravenous diltiazem in patients with normal versus impaired ventricular function.
Remme WJ; Krauss XH; van Hoogenhuyze DC; Kruyssen DA
J Am Coll Cardiol; 1993 Mar; 21(3):709-20. PubMed ID: 8436753
[TBL] [Abstract][Full Text] [Related]
9. Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.
Condorelli M; Brevetti G; Chiariello M; Miceli D; Lavecchia G; Paudice G; Verrienti S
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):101S-110S. PubMed ID: 7093092
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and adrenergic effects of combined alpha/beta-receptor blockade versus combined beta-receptor and slow channel calcium blockade in patients with ischemic heart disease.
Koch G; Fransson L
Int J Cardiol; 1989 Oct; 25(1):73-9. PubMed ID: 2793265
[TBL] [Abstract][Full Text] [Related]
11. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
Mehta J; Feldman RL; Marx JD; Kelly GA
Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
[TBL] [Abstract][Full Text] [Related]
12. Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.
Silke B; Nelson GI; Ahuja RC; Taylor SH
Br Heart J; 1982 Oct; 48(4):364-71. PubMed ID: 7126388
[TBL] [Abstract][Full Text] [Related]
13. Acute antianginal hemodynamic effects of nicardipine in coronary artery disease.
Lambert CR; Pepine CJ
Am Heart J; 1990 Feb; 119(2 Pt 2):457-62. PubMed ID: 2301244
[TBL] [Abstract][Full Text] [Related]
14. Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
Visser CA; Jaarsma W; Kan G; Lie KI
Postgrad Med J; 1984; 60 Suppl 4():17-20. PubMed ID: 6527974
[TBL] [Abstract][Full Text] [Related]
15. Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris.
Lambert CR; Hill JA; Feldman RL; Pepine CJ
Am J Cardiol; 1987 Sep; 60(7):471-6. PubMed ID: 3630928
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
Koch G; Fransson L
Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamics of nicardipine in coronary artery disease.
Visser CA; Koolen JJ; van Wezel H; Dunning AJ
Am J Cardiol; 1987 Jun; 59(17):9J-12J. PubMed ID: 3300240
[TBL] [Abstract][Full Text] [Related]
18. [Systemic and coronary hemodynamic effects of intravenous nicardipine at rest and in ischemia induced by rapid atrial stimulation].
Berland J; Savin T; Saoudi N; Cribier A; Letac B
Arch Mal Coeur Vaiss; 1987 Sep; 80(10):1513-21. PubMed ID: 3125811
[TBL] [Abstract][Full Text] [Related]
19. Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.
Frishman WH
Cardiovasc Drugs Ther; 1988 Sep; 2(3):343-53. PubMed ID: 2908732
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and metabolic effects of diltiazem during coronary sinus pacing with particular reference to left ventricular ejection fraction.
Josephson MA; Hopkins J; Singh BN
Am J Cardiol; 1985 Feb; 55(4):286-90. PubMed ID: 3969863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
